title: Use of intravenous tacrolimus to reverse vascular rejection in kidney and simultaneous kidney-pancreas transplantation.
authors.affiliation: Department of Surgery, University of Miami School of Medicine, FL 33101, USA.
authors.forename: G
authors.initials: G
authors.lastname: Ciancio
authors.forename: G
authors.initials: G
authors.lastname: Burke
authors.forename: A
authors.initials: A
authors.lastname: Viciana
authors.forename: P
authors.initials: P
authors.lastname: Ruiz
authors.forename: D
authors.initials: D
authors.lastname: Roth
authors.forename: T F
authors.initials: TF
authors.lastname: Khan
authors.forename: B
authors.initials: B
authors.lastname: Montane
authors.forename: J
authors.initials: J
authors.lastname: Strauss
authors.forename: J
authors.initials: J
authors.lastname: Miller
mesh_terms: D000328:Adult; D003404:Creatinine / Q000097:blood; D006084:Graft Rejection / Q000188:drug therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D007275:Injections, Intravenous; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D009173:Mycophenolic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use; D016035:Pancreas Transplantation / Q000276:immunology* / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D003404:Creatinine; D009173:Mycophenolic Acid; D016559:Tacrolimus